Neuropathy Target Esterase

Hayes' Handbook of Pesticide Toxicology

Volumn , Issue , 2010, Pages 1435-1455

  Wijeyesakere, Sanjeeva J ^a   Richardson, Rudy J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882769559     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374367-1.00067-7     Document Type: Chapter

References (139)

1. Akassoglou K., Malester B., Xu J., Tessarollo L., Rosenbluth J., Chao M.V. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc. Natl. Acad. Sci. USA 2004, 101:5075-5080.
2. Aldridge W.N., Reiner E. Enzyme Inhibitors as Substrates 1972, Elsevier/North-Holland, Amsterdam.
3. Atkins J., Glynn P. Membrane association and critical residues in the catalytic domain of human neuropathy target esterase. J. Biol. Chem. 2000, 275:24477-24483.
4. Barril J., Vilanova E. Reversible inhibition can profoundly mislead studies on progressive inhibition of enzymes: the interaction of paraoxon with soluble neuropathy target esterase. Chem. Biol. Interact. 1997, 108:19-25.
5. 1120:541-550.
6. Battershill J.M., Edwards P.M., Johnson M.K. Toxicological assessment of isomeric pesticides: a strategy for testing of chiral organophosphorus (OP) compounds for delayed polyneuropathy in a regulatory setting. Food Chem. Toxicol. 2004, 42:1279-1285.
7. Bertoncin D., Russolo A., Caroldi S., Lotti M. Neuropathy target esterase in human lymphocytes. Arch. Environ. Health 1985, 40:139-144.
8. Borhan B., Ko Y., Wilson B.W., Kurth M.J., Hammock B.D. Development of surrogate substrates for neuropathy target esterase. Biochim. Biophys. Acta 1995, 1250:171-182.
9. Bourne Y., Taylor P., Bougis P.E., Marchot P. Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly. J. Biol. Chem. 1999, 274:2963-2970.
10. Capodicasa E., Scapellato M.L., Moretto A., Caroldi S., Lotti M. Chlorpyrifos-induced delayed polyneuropathy. Arch. Toxicol. 1991, 65:150-155.
11. 1158:277-283.
12. Casida J.E., Nomura D.K., Vose S.C., Fujioka K. Organophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoids. Chem. Biol. Interact. 2008, 175:355-364.
13. Céspedes M.V., Escudero M.A., Barril J., Sogorb M.A., Vicedo J.L., Vilanova E. Discrimination of carboxylesterases of chicken neural tissue by inhibition with neuropathic and non-neuropathic organophosphorus compounds and a neuropathy promoter. Chem. Biol. Interact. 1997, 106:191-200.
14. Clothier B., Johnson M.K. Rapid aging of neurotoxic esterase after inhibition by di-isopropyl phosphorofluoridate. Biochem. J. 1979, 177:549-558.
15. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 2005, 6:889-898.
16. Davis C.S., Richardson R.J. Organophosphorus compounds. Experimental and Clinical Neurotoxicology 1980, 527-544. Williams & Wilkins, Baltimore. P.S. Spencer, H.H. Schaumburg (Eds.).
17. Davis C.S., Richardson R.J. Neurotoxic esterase: characterization of the solubilized enzyme and the conditions for its solubilization from chicken brain microsomal membranes with ionic, zwitterionic, or non-ionic detergents. Biochem. Pharmacol. 1987, 36:1393-1399.
18. Davis C.S., Johnson M.K., Richardson R.J. Organophosphorus compounds. Neurotoxicity of Industrial and Commercial Chemicals 1985, Vol. 2:1-23. CRC Press, Boca Raton, FL. J.L. O'Donoghue (Ed.).
19. De Jager A.E.J., Van Weerden T.W., Houthhoff H.J., de Monchy J.G.R. Polyneuropathy after massive exposure to parathion. Neurology 1981, 31:603-605.
20. Dessen A., Tang J., Schmidt H., Stahl M., Clark J., Seehra J., Somers W. Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell 1999, 97:349-360.
21. Dickoff D.J., Gerber O., Turovsky Z. Delayed neurotoxicity after ingestion of carbamate pesticide. Neurology 1987, 37:1229-1231.
22. Dudek B.R., Richardson R.J. Occurrence of neurotoxic esterase in various tissues of hen [abstract]. Toxicol. Appl. Pharmacol. 1978, 45:269-270.
23. Dudek B.R., Richardson R.J. Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen. Biochem. Pharmacol. 1982, 31:1117-1121.
24. el-Fawal H.A., Ehrich M.F. Calpain activity in organophosphorus-induced delayed neuropathy (OPIDN): effects of a phenylalkylamine calcium channel blocker. Ann. N. Y. Acad. Sci. 1993, 28:325-329.
25. Escudero M.A., Vilanova E. Purification and characterization of naturally soluble neuropathy target esterase from chicken sciatic nerve by HPLC and Western blot. J. Neurochem. 1997, 69:1975-1982.
26. Organophosphorus Pesticides and Long-Term Effects on the Nervous System 1998, European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Technical Report No. 75, ECETC, Brussels.
27. Garcia-Pérez A.G., Barril J., Estévez J., Vilanova E. Properties of phenyl valerate esterase activities from chicken serum are comparable with soluble esterases of peripheral nerves in relation with organophosphorus compounds inhibition. Toxicol. Lett. 2003, 30:1-10.
28. Glynn P. Neuropathy target esterase. Biochem. J. 1999, 344:625-631.
29. Glynn P. Neural development and neurodegeneration: two faces of neuropathy target esterase. Prog. Neurobiol. 2000, 61:61-74.
30. Glynn P. A mechanism for organophosphate-induced delayed neuropathy. Toxicol. Lett. 2006, 162:94-97.
31. 3H]DFP-labelled polypeptide. Chem. Biol. Interact. 1993, 87:361-367.
32. Glynn P., Read D.J., Guo R., Wylie S., Johnson M.K. Synthesis and characterisation of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: neuropathy target esterase. Biochem. J. 1994, 301:551-556.
33. Glynn P., Holton J.L., Nolan C.C., Read D.J., Brown L., Hubbard A., Cavanagh J.B. Neuropathy target esterase: immunolocalisation to neuronal cell bodies and axons. Neuroscience 1998, 83:295-302.
34. Hein, N. D. (2009). Mechanisms of prediction and potential causation of organophosphate induced delayed neurotoxicity. PhD dissertation, University of Michigan, Ann Arbor.
35. Hierons R., Johnson M.K. Clinical and toxicological investigations of a case of delayed neuropathy in man after acute poisoning by an organophosphorus pesticide. Arch. Toxicol. 1978, 40:279-284.
36. Ito D., Suzuki N. Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain 2009, 132:8-15.
37. Johnson M.K. A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds. Biochem. J. 1969, 111:487-495.
38. Johnson M.K. The delayed neurotoxic effect of some organophosphorus compounds: Identification of the phosphorylation site as an esterase. Biochem. J. 1969, 114:711-714.
39. Johnson M.K. Organophosphorus and other inhibitors of "neurotoxic esterase" and the development of delayed neurotoxicity in hens. Biochem. J. 1970, 120:523-531.
40. Johnson M.K. The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J. Neurochem. 1974, 23:785-789.
41. Johnson M.K. Organophosphorus esters causing delayed neurotoxic effects: mechanism of action and structure/activity relationships. Arch. Toxicol. 1975, 34:259-288.
42. Johnson M.K. Structure-activity relationships for substrates and inhibitors of hen brain neurotoxic esterase. Biochem. Pharmacol. 1975, 24:797-805.
43. Johnson M.K. The anomalous behaviour of some dimethyl-phosphates in the biochemical test for delayed neurotoxicity potential. Arch. Toxicol. 1978, 41:107-110.
44. Johnson M.K. Delayed neurotoxicity - do trichlorphon and/or dichlorvos cause delayed neuropathy in man or in test animals?. Acta Pharmacol. Toxicol. 1981, 49:87-98.
45. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. "Reviews in Biochemical Toxicology" 1982, Vol. 4:141-212. Elsevier, New York. E. Hodgson, J.R. Bend, R.M. Philpot (Eds.).
46. Johnson M.K. Check your paraoxon and parathion for neurotoxic impurities. Vet. Hum. Toxicol. 1982, 24:220a.
47. Johnson M.K. Delayed neurotoxicity tests of organophosphorus esters: a proposed protocol integrating neuropathy target esterase (NTE) assays with behaviour and histopathology tests to obtain more information more quickly from fewer animals. Proceedings of the International Conference on Environmental Hazards of Agrochemicals in Developing Countries, Alexandria, Egypt, November 8-12, 1983 1984, 474-493. University of Alexandria, Alexandria, Egypt. A.H. El-Sebaed, (Ed.).
48. Johnson M.K. The importance of chirality in influencing both acute and delayed neuropathic toxicity of organophosphorus esters. Toxicol. Environ. Chem. 1987, 14:321-335.
49. Johnson M.K. Sensitivity and selectivity of compounds interacting with neuropathy target esterase: further structure/activity studies. Biochem. Pharmacol. 1988, 37:4095-4104.
50. Johnson M.K. Organophosphates and delayed neuropathy - Is NTE alive and well?. Toxicol. Appl. Pharmacol. 1990, 102:385-399.
51. Johnson M.K., Lauwerys R.R. Protection by some carbamates against the delayed neurotoxic effect of di-isopropyl phosphorofluoridate. Nature (London) 1969, 222:1066-1067.
52. Johnson M.K., Lotti M. Delayed neurotoxicity caused by chronic feeding of organophosphates requires a high-point of inhibition of neurotoxic esterase. Toxicol. Lett. 1980, 5:99-102.
53. Johnson M.K., Read D.J. The influence of chirality on the delayed neuropathic potential of some organophosphorus esters: neuropathic and prophylactic effects of stereoisomers of ethyl phenylphosphonic acid (EPN oxon and EPN) correlate with quantities of aged and unaged neuropathy target esterase in vivo. Toxicol. Appl. Pharmacol. 1987, 90:103-115.
54. Johnson M.K., Vilanova E., Read D.J. Anomalous biochemical responses in tests of the delayed neuropathic potential of methamidophos (O, S-dimethyl phosphorothioamidate), its resolved isomers and of some higher O-alkyl homologues. Arch. Toxicol. 1991, 65:618-624.
55. Kang Y.C., Kim K.M., Lee K.S., Namkoong S., Lee S.J., Han J.A., Jeoung D., Ha K.S., Kwon Y.G., Kim Y.M. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation. Cell Death Differ. 2004, 11:1287-1298.
56. Kayyali U.S., Moore T.B., Randall J.C., Richardson R.J. Neurotoxic esterase (NTE) assay: optimized conditions based on detergent-induced shifts in the phenol/4-aminoantipyrine chromophore spectrum. J. Anal. Toxicol. 1991, 15:86-89.
57. Kohli N., Srivastava D., Sun J., Richardson R.J., Lee I.S., Worden R.M. Nanostructured biosensor for measuring neuropathy target esterase activity. Anal. Chem. 2007, 79:5196-5203.
58. Kretzschmar D., Hasan G., Sharma S., Heisenberg M., Benzer S. The Swiss cheese mutant causes glial hyperwrapping of and brain degeneration in Drosophila. J. Neurosci. 1997, 17:7425-7432.
59. Kropp T.J., Richardson R.J. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. J. Toxicol. Environ. Health A 2003, 66:1145-1157.
60. Kropp T.J., Glynn P., Richardson R.J. The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry 2004, 43:3716-3722.
61. Lim J., Crespo-Barreto J., Jafar-Nejad P., Bowman A.B., Richman R., Hill D.E., Orr H.T., Zoghbi H.Y. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 2008, 452:713-718.
62. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol. 1992, 21:465-487.
63. Lotti M. Cholinesterase inhibition: complexities in interpretation. Clin. Chem. 1995, 41:1814-1818.
64. Lotti M., Johnson M.K. Neurotoxicity of organophosphorus pesticides: Predictions can be based on in vitro studies with hen and human enzymes. Arch. Toxicol. 1978, 41:215-221.
65. Lotti M., Johnson M.K. Repeated small doses of a neurotoxic organophosphate: Monitoring of neurotoxic esterase in brain and spinal cord. Arch. Toxicol. 1980, 45:263-271.
66. Lotti M., Johnson M.K. Neurotoxic esterase in human nervous tissue. J. Neurochem. 1980, 34:747-749.
67. 1120:519-524.
68. Lotti M., Ferrara S.D., Caroldi S., Sinigaglia F. Enzyme studies with human and hen autopsy tissue suggest omethoate does not cause delayed neuropathy in man. Arch. Toxicol. 1981, 48:265-270.
69. Lotti M., Becker C.E., Aminoff M.J., Woodrow J.E., Seiber J.N., Talcott R.E., Richardson R.J. Occupational exposure to the cotton defoliants DEF and merphos. A rational approach to monitoring organophosphorus-induced delayed neurotoxicity. J. Occup. Med. 1983, 25:517-522.
70. Lotti M., Moretto A., Zoppellari R., Dainese R., Rizzuto N., Barusco G. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch. Toxicol. 1986, 59:176-179.
71. Lush M.J., Li Y., Read D.J., Willis A.C., Glynn P. Neuropathy target esterase and a homologous Drosophila neurodegeneration mutant protein contain a domain conserved from bacteria to man. Biochem. J. 1998, 332:1-4.
72. Mackay C.E., Hammock B.D., Wilson B.W. Identification and isolation of a 155kDa protein with neuropathy target esterase activity. Fundam. Appl. Toxicol. 1996, 30:23-30.
73. Makhaeva G.F., Sigolaeva L.V., Zhuravleva L.V., Eremenko A.V., Kuorchkin I.N., Richardson R.J., Malygin V.V. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. J. Toxicol. Environ. Health A 2003, 66:599-610.
74. Makhaeva G.F., Malygin V.V., Strakhova N.N., Sigolaeva L.V., Sokolovskaya L.G., Eremenko A.V., Kurochkin I.N., Richardson R.J. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress. Hum. Exp. Toxicol. 2007, 26:273-282.
75. Maroni M., Bleecker M.L. Neuropathy target esterase in human lymphocytes and platelets. J. Appl. Toxicol. 1986, 6:1-7.
76. McConnell R., Delgado-Téllez E., Cuadra R., Tórres E., Keifer M., Almendárez J., Miranda J., El-Fawal H.A., Wolff M., Simpson D., Lundberg I. Organophosphate neuropathy due to methamidophos: biochemical and neurophysiological markers. Arch. Toxicol. 1999, 73:296-300.
77. Meredith C., Johnson M.K. Neuropathy target esterase: Rates of turnover in vivo following covalent inhibition with phenyl di-n-pentylphosphinate. J. Neurochem. 1988, 51:1097-1101.
78. Milatovic D., Moretto A., Osman K.A., Lotti M. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy. Chem. Res. Toxicol. 1997, 10:1045-1048.
79. Moolenaar W.H. Lysophospholipids in the limelight: autotaxin takes center stage. J. Cell Biol. 2002, 158:197-199.
80. Moolenaar W.H., Kranenburg O., Postma F.R., Zondag G.C. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr. Opin. Cell Biol. 1997, 9:168-173.
81. Moretto A., Lotti M. Poisoning by organophosphorus insecticides and sensory neuropathy. J. Neurol. Neurosurg. Psychiatr. 1998, 64:463-468.
82. 1158:285-291.
83. Moretto A., Nicolli A., Lotti M. The search of the target of promotion: phenylbenzoate esterase activities in hen peripheral nerve. Toxicol. Appl. Pharmacol. 2007, 219:196-201.
84. Moser M., Stempl T., Li Y., Glynn P., Buttner R., Kretzschmar D. Molecular cloning of the mouse NTE/SWS gene. Mech. Dev. 2000, 90:279-282.
85. Mühlig-Versen M., da Cruz A.B., Tschäpe J.A., Moser M., Büttner R., Athenstaedt K., Glynn P., Kretzschmar D. Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila. J. Neurosci. 2005, 25:2865-2873.
86. Nardini M., Dijkstra B.W. a/ß Hydrolase fold enzymes: the family keeps growing. Curr. Opin. Struct. Biol. 1999, 9:732-737.
87. Nieto-Miguel T., Fonteriz R.I., Vay L., Gajate C., López-Hernández S., Mollinedo F. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res. 2007, 67:10368-10378.
88. Novak R., Padilla S. An in vitro comparison of rat and chicken brain neurotoxic esterase. Fundam. Appl. Toxicol. 1986, 6:464-471.
89. "Delayed neurotoxicity of organophosphorus substances following acute exposure" and "Delayed neurotoxicity of organophosphorus substances: 28-day repeated dose study". "Guidelines for Testing of Chemicals 418 and 419 1995, Organization for Economic Co-operation and Development (OECD), Environmental Health and Safety Division, OECD, Paris.
90. Pennuto M., Palazzolo I., Poletti A. Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity. Hum. Mol. Genet. 2009, 18:R40-R47.
91. Pope C.N., Padilla S.S. Modulation of neurotoxic esterase activity in vitro by phospholipids. Toxicol. Appl. Pharmacol. 1989, 97:272-278.
92. Pope C.N., Padilla S.S. Chromatographic characterization of neurotoxic esterase. Biochem. Pharmacol. 1989, 38:181-188.
93. Poulsen E., Aldridge W.N. Studies on esterases in the chicken nervous system. Biochem. J. 1964, 90:182-189.
94. Quistad G.B., Casida J.E. Lysophospholipase inhibition by organophosphorus toxicants. Toxicol. Appl. Pharmacol. 2004, 196:319-326.
95. Quistad G.B., Barlow C., Winrow C.J., Sparks S.E., Casida J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc. Natl. Acad. Sci. USA 2003, 100:7983-7987.
96. Raff M.C., Whitmore A.V., Finn J.T. Axonal self-destruction and neurodegeneration. Science 2002, 296:868-871.
97. Rainier S., Bui M., Mark E., Thomas D., Tokarz D., Ming L., Delaney C., Richardson R.J., Albers J.W., Matsunami N., Stevens J., Coon H., Leppert M., Fink J.K. Neuropathy target esterase gene mutations cause motor neuron disease. Am. J. Hum. Genet. 2008, 82:780-785.
98. Randall J.C., Yano B.L., Richardson R.J. Potentiation of organophosphorus compound-induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: Distribution of axonal lesions. J. Toxicol. Environ. Health 1997, 51:571-590.
99. Richardson R.J. Neurotoxic esterase: normal and pathogenic roles. Cellular and Molecular Neurotoxicology 1984, 285-295. Raven Press, New York. T. Narahashi, (Ed.).
100. Richardson R.J. Interactions of organophosphorus compounds with neurotoxic esterase. Organophosphates: Chemistry, Fate and Effects 1992, 299-323. Academic Press, San Diego. J.E. Chambers, P.E. Levi (Eds.).
101. Richardson R.J. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature. J. Toxicol. Environ. Health 1995, 44:135-165.
102. Richardson R.J. Neurotoxicity, delayed. Encyclopedia of Toxicology" 2005, Vol. 2:302-306. Academic Press, New York. 2nd ed.,. P. Wexler, (Ed.).
103. Richardson R.J., Dudek B.R. Neurotoxic esterase: characterization and potential for a predictive screen for exposure to neuropathic organophosphates. "Pesticide Chemistry: Human Welfare and the Environment 1983, Vol. 3:491-495. Pergamon, Oxford. J. Miyamoto, P.C. Kearney (Eds.).
104. Richardson R.J., Davis C.S., Johnson M.K. Subcellular distribution of marker enzymes and of neurotoxic esterase in adult hen brain. J. Neurochem. 1979, 32:607-615.
105. Richardson R.J., Moore T.B., Kayyali U.S., Fowke J.H., Randall J.C. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in vivo and kinetics of inhibition by chlorpyrifos oxon in vitro: application to assessment of neuropathic risk. Fundam. Appl. Toxicol. 1993, 20:273-279.
106. Richardson R.J., Moore T.B., Kayyali U.S., Randall J.C. Chlorpyrifos: assessment of potential for delayed neurotoxicity by repeated dosing in adult hens with monitoring of brain acetylcholinesterase, brain and lymphocyte neurotoxic esterase, and plasma butyrylcholinesterase activities. Fundam. Appl. Toxicol. 1993, 21:89-96.
107. Richardson R.J., Worden R.M., Makhaeva G.F. Biomarkers and biosensors of delayed neuropathic agents. Handbook of Toxicology of Chemical Warfare Agents 2009, 859-876. Elsevier, Amsterdam. R.C. Gupta, (Ed.).
108. Rueffer-Turner M.E., Read D.J., Johnson M.K. Purification of neuropathy target esterase from avian brain after prelabelling with [3H]di-isopropyl phosphorofluoridate. J. Neurochem. 1992, 58:135-141.
109. Rydel T.J., Williams J.M., Krieger E., Moshiri F., Stallings W.C., Brown S.M., Pershing J.C., Purcell J.P., Alibhai M.F. The crystal structure, mutagenesis, and activity studies reveal that patatin is a lipid acyl hydrolase with a Ser-Asp catalytic dyad. Biochemistry 2003, 42:6696-6708.
110. Schwab B.W., Richardson R.J. Lymphocyte and brain neurotoxic esterase: dose and time dependence of inhibition in the hen examined with three organophosphorus esters. Toxicol. Appl. Pharmacol. 1986, 83:1-9.
111. Senanayake N., Johnson M.K. Acute polyneuropathy after poisoning by a new organophosphorus insecticide. N. Engl. J. Med. 1982, 306:155-156.
112. Smith M.I., Elvove E., Frazier W.H. The pharmacological action of certain phenol esters with special reference to the etiology of the so-called ginger paralysis. Public Health Rep. 1930, 45:2509-2524.
113. Sogorb M.A., Viniegra S., Reig J.A., Vilanova E. Partial characterization of neuropathy target esterase and related phenyl valerate esterases from bovine adrenal medulla. J. Biochem. Toxicol. 1994, 9:145-152.
114. Sogorb M.A., Bas S., Gutierrez L.M., Vilanova E., Viniegra S. Bovine chromaffin cells as an in vitro model for the study of non-cholinergic toxic effects of organophosphorus compounds. Arch. Toxicol. Suppl. 1997, 19:347-355.
115. Soliman S.A., Curley A., Farmer J., Novak R. In vivo inhibition of chicken brain acetylcholinesterase and neurotoxic esterase in relation to the delayed neurotoxicity of leptophos and cyanophenphos. J. Environ. Pathol. Toxicol. Oncol. 1986, 7:211-224.
116. Stafford R.E., Fanni T., Dennis E.A. Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry 1989, 28:5113-5120.
117. Taylor P. Impact of recombinant DNA technology and protein structure determination on past and future studies on acetylcholinesterase. Multi-disciplinary Approaches to Cholinesterase Functions 1992, 1-15. Plenum, New York. A. Shafferman, B. Velan (Eds.).
118. Thomas T.C., Szekacs A., Rojas S., Hammock B.D., Wilson B.W., MacNamee M.G. Characterization of neuropathy target esterase using trifluoromethyl ketones. Biochem. Pharmacol. 1990, 40:2587-2596.
119. Thompson C.M., Richardson R.J. Anticholinesterase insecticides. Pesticide Toxicology and International Regulation 2004, 89-127. Wiley, Chichester, UK. T.C. Marrs, B. Ballantyne (Eds.).
120. Umehara F., Izumo S., Arimura K., Osame M. Polyneuropathy induced by m-tolyl methyl carbamate intoxication. J. Neurol. 1991, 238:47-48.
121. Pesticide Assessment Guidelines, Subdivision F; Hazard Evaluation: Human and Domestic Animals: Addendum 10, Neurotoxicity 1991, U.S. Environmental Protection Agency (EPA), Series 81-83, pp. 3-12, EPA 540/09-91-123, PB 91-154617, Health Effects Division, Office of Pesticide Programs, U.S. EPA, Washington, DC.
122. van Tienhoven M., Atkins J., Li Y., Glynn P. Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J. Biol. Chem. 2002, 277:20942-20948.
123. Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol. Rev. 2005, 85:201-279.
124. Veronesi B., Padilla S., Lyerly D. The correlation between neurotoxic esterase inhibition and mipafox-induced neuropathic damage in rats. Neurotoxicology 1986, 7:207-215.
125. Veronesi B., Padilla S., Blackmon K., Pope C. Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN). Toxicol. Appl. Pharmacol. 1991, 107:311-324.
126. Veronesi B., Ehrich M., Blusztajn J.K., Oortgiesen M., Durham H. Cell culture models of interspecies selectivity to organophosphorus insecticides. Neurotoxicology 1997, 18:283-297.
127. 1120:525-540.
128. Vose S.C., Fujioka K., Gulevich A.G., Lin A.Y., Holland N.T., Casida J.E. Cellular function of neuropathy target esterase in lysophosphatidylcholine action. Toxicol. Appl. Pharmacol. 2008, 232:376-383.
129. Wang A., Dennis E.A. Mammalian lysophospholipases. Biochim. Biophys. Acta 1999, 1439:1-16.
130. Wijeyesakere, S. J. (2009). Enzyme aging: structural insights from NTE and patatin. PhD dissertation, University of Michigan, Ann Arbor.
131. Wijeyesakere S.J., Richardson R.J., Stuckey J.A. Modeling the tertiary structure of the patatin domain of neuropathy target esterase. Protein J. 2007, 26:165-172.
132. Wijeyesakere S.J., Stuckey J.A., Richardson R.J. Molecular modeling predicts conformational changes in the neuropathy target esterase (NTE) catalytic domain (PNTE) after inhibition and aging [abstract]. Toxicologist 2007, 96:186.
133. Wijeyesakere S.J., Stuckey J.A., Richardson R.J. Structural insight into inhibition/aging of neuropathy target esterase (NTE) from x-ray crystal studies of its catalytic domain homologue, patatin-17 (pat17) [abstract]. Toxicologist 2009, 108:286-287.
134. Williams D.G., Johnson M.K. Gel electrophoretic identification of hen brain neurotoxic esterase labelled with tritiated di-isopropyl phosphorofluoridate. Biochem. J. 1981, 199:323-333.
135. Wilson B.W., Henderson J.D. Blood esterase determinations as markers of exposure. Rev. Environ. Contam. Toxicol. 1992, 128:55-69.
136. Winrow C.J., Hemming M.L., Allen D.M., Quistad G.B., Casida J.E., Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat. Genet. 2003, 33:477-485.
137. Xiu X., Puskar N.L., Shanata J.A.P., Lester H.A., Dougherty D.A. Nicotine binding to brain receptors requires a strong cation-pφ interaction. Nature 2009, 458:534-537.
138. 3H]benzodioxaphosphorin 2-oxide. J. Neurochem. 1995, 64:1680-1687.
139. Zaccheo O., Dinsdale D., Meacock P.A., Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J. Biol. Chem. 2004, 279:24024-24033.